Certain common stock of fate therapeutics, inc. are subject to a lock-up agreement ending on 11-nov-2019.

Certain common stock of fate therapeutics, inc. are subject to a lock-up agreement ending on 11-nov-2019. these common stock will be under lockup for 61 days starting from 11-sep-2019 to 11-nov-2019. details: the company, executive officers and directors have agreed subject to specified exceptions, not to directly or indirectly, sell, offer, contract or grant any option to sell (including any short sale), pledge, transfer, establish an open “put equivalent position” within the meaning of rule 16a-l(h) under the exchange act; otherwise dispose of any shares of common stock, options or warrants to acquire shares of common stock, or securities exchangeable or exercisable for or convertible into shares of common stock currently or hereafter owned either of record or beneficially; or publicly announce an intention to do any of the foregoing for a period of 60 days after the date of this prospectus supplement without the prior written consent of the representatives.
FATE Ratings Summary
FATE Quant Ranking